Cure51

Seed
cure51.com Biotech & Healthcare
Total Funding $16M
Latest Round $16M Seed
Last Announced Mar 20, 2024
Investors Undisclosed
Decision Makers 6 Verified

About Cure51

Innovative French TechBio company dedicated to finding novel Cancer treatments based on exceptional Cancer survivors' biology.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website cure51.com
Domain Registered Date Sep 27, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $16,000,000 · Seed

    startupintros.com

  2. Milestone

    Website domain registered

    cure51.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cure51.

Funding History

1 Round
Seed · Mar 20, 2024

Founders & Leadership

5

EL MEHDI OUZGANE

Late Founder COO

Work email & phone locked Unlock →

NICOLAS WOLIKOW

Co-Founder CEO

Work email & phone locked Unlock →

PALOMA CEJAS

Late Founder Head of Translational Research

Work email & phone locked Unlock →

RÉMY NICOLLE

Late Founder Senior Advisor

Work email & phone locked Unlock →

SIMON ISTOLAINEN

Co-Founder Chief Strategy Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts